Recent developments in identifying genetic determinants of premature ovarian failure

Sexual Development

Volumn 2, Issue 4-5, 2008, Pages 228-243

  Skillern, A ^a   Rajkovic, A ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Candidate genes; Menopause; Mouse models; Oocyte; Ovary; Premature ovarian failure

Indexed keywords

BONE MORPHOGENETIC PROTEIN 15; FOLLITROPIN RELEASING FACTOR; FORKHEAD TRANSCRIPTION FACTOR; FRAGILE X MENTAL RETARDATION PROTEIN; GROWTH DIFFERENTIATION FACTOR 9; OCTAMER TRANSCRIPTION FACTOR 4; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; RNA BINDING PROTEIN; TRANSCRIPTION FACTOR FKHRL1; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR GATA 6;

CONFERENCE PAPER; GENE EXPRESSION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; HUMAN; NONHUMAN; OVARY FOLLICLE DEVELOPMENT; PREMATURE OVARIAN FAILURE; PRIORITY JOURNAL; RISK FACTOR; TURNER SYNDROME; X CHROMOSOME;

ANIMALS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MICE; OVARIAN FAILURE, PREMATURE; OVARIAN FOLLICLE;

MUS MUSCULUS;

EID: 55749098336     PISSN: 16615425     EISSN: 16615433     Source Type: Journal    
DOI: 10.1159/000152039     Document Type: Conference Paper

References (200)

1. Ackert CL, Gittens JE, O'brien MJ, Eppig JJ, Kidder GM: Intercellular communication via Connexin43 gap junctions is required for ovarian folliculogenesis in the mouse. Dev Biol 233:258-270 (2001).
2. Agoulnik LY, Cho Y, Niederberger C, Kieback DG, Cooney AJ: Cloning, expression analysis and chromosomal localization of the human nuclear receptor gene GCNF. FEBS Lett 424:73-78 (1998).
3. Aittomäki K, Lucena JL, Pakarinen P, Sistonen P, Tapanainen J, et al: Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell 82:959-968 (1995).
4. Allen EG, Sullivan AK, Marcus M, Small C, Dominguez C, et al: Examination of reproductive aging milestones among women who carry the FMR1 premutation. Hum Reprod 22:2142-2152 (2007).
5. Allen LA, Achermann JC, Pakarinen P, Kotlar TJ, Huhtaniemi IT, et al: A novel loss of function mutation in exon 10 of the FSH receptor gene causing hypergonadotropic hypogonadism: clinical and molecular characteristics. Hum Reprod 18:251-256 (2003).
6. Anasti JN: Premature ovarian failure: an update. Fertil Steril 70:1-15 (1998).
7. Anasti JN, Kalantaridou SN, Kimzey LM, Defensor RA, Nelson LM: Bone loss in young women with karyotypically normal spontaneous premature ovarian failure. Obstet Gynecol 91:12-15 (1998).
8. Anderson RA, Fulton N, Cowan G, Coutts S, Saunders PT: Conserved and divergent patterns of expression of DAZL, VASA and OCT4 in the germ cells of the human fetal ovary and testis. BMC Dev Biol 18:136 (2007).
9. Anttonen M, Ketola I, Parviainen H, Pusa AK, Heikinheimo M: FOG-2 and GATA-4 are co-expressed in the mouse ovary and can modulate mullerian-inhibiting substance expression. Biol Reprod 68:1333-1340 (2003).
10. Bayne RA, Martins da Silva SJ, Anderson RA: Increased expression of the FIGLA transcription factor is associated with primordial follicle formation in the human fetal ovary. Mol Hum Reprod 10:373-381 (2004).
11. Beau I, Touraine P, Meduri G, Gougeon A, Desroches A, et al: A novel phenotype related to partial loss of function mutations of the follicle stimulating hormone receptor. J Clin Invest 102:1352-1359 (1998).
12. Bione S, Rizzolio F, Sala C, Ricotti R, Goegan M, et al: Mutation analysis of two candidate genes for premature ovarian failure, DACH2 and POF1B. Hum Reprod 19:2759-2766 (2004).
13. Bodega B, Porta C, Crosignani PG, Ginelli E, Marozzi A: Mutations in the coding region of the FOXL2 gene are not a major cause of idiopathic premature ovarian failure. Mol Hum Reprod 10:555-557 (2004).
14. Bodega B, Bione S, Dalpra L, Toniolo D, Ornaghi F, et al: Influence of intermediate and uninterrupted FMR1 CGG expansions in premature ovarian failure manifestation. Hum Reprod 21:952-957 (2006).
15. Braw-Tal R, McNatty KP, Smith P, Heath DA, Hudson NL, et al: Ovaries of ewes homozygous for the X-linked Inverdale gene (FecXI) are devoid of secondary and tertiary follicles but contain many abnormal structures. Biol Reprod 49:895-907 (1993).
16. Bretherick KL, Fluker MR, Robinson WP: FMR1 repeat sizes in the gray zone and high end of the normal range are associated with premature ovarian failure. Hum Genet 117:376-382 (2005).
17. Bullejos M, Koopman P: Germ cells enter meiosis in a rostrocaudal wave during development of the mouse ovary. Mol Reprod Dev 68:422-428 (2004).
18. Cantley LC: The phosphoinositide 3-kinase pathway. Science 296:1655-1657 (2002).
19. Carabatsos MJ, Elvin J, Matzuk MM, Albertini DF: Characterization of oocyte and follicle development in growth differentiation factor-9-deficient mice. Dev Biol 204:373-384 (1998).
20. Castrillon DH, Quade BJ, Wang TY, Quigley C, Crum CP: The human VASA gene is specifically expressed in the germ cell lineage. Proc Natl Acad Sci USA 97:9585-9590 (2000).
21. Castrillon DH, Miao L, Kollipara R, Homer JW, DePinho RA: Suppression of ovarian follicle activation in mice by the transcription factor Foxo3a. Science 301:215-218 (2003).
22. Chatterjee S, Modi D, Maitra A, Kadam S, Patel Z, et al: Screening for FOXL2 gene mutations in women with premature ovarian failure: an Indian experience. Reprod Biomed Online 15:554-560 (2007).
23. Chen F, Cooney AJ, Wang Y, Law SW, O'Malley BW: Cloning of a novel orphan receptor (GCNF) expressed during germ cell development. Mol Endocrinol 8:1434-1444 (1994).
24. Choi Y, Rajkovic A: Genetics of early mammalian folliculogenesis. Cell Mol Life Sci 63:579-590 (2006a).
25. Choi Y, Rajkovic A: Characterization of NOBOX DNA binding specificity and its regulation of Gdf9 and Pou5f1 promoters. J Biol Chem 281:35747-35756 (2006b).
26. Conway GS, Payne NN, Webb J, Murray A, Jacobs PA: Fragile X premutation screening in women with premature ovarian failure. Hum Reprod 13:1184-1187 (1998).
27. Cooke HJ, Lee M, Kerr S, Ruggiu M: A murine homologue of the human DAZ gene is autosomal and expressed only in male and female gonads. Hum Mol Genet 5:513-516 (1996).
28. Coulam CB, Adamson SC, Annegers JF: Incidence of premature ovarian failure. Obstet Gynecol 67:604-606 (1986).
29. Cremers FP, van de Pol DJ, Diergaarde PJ, Wieringa B, Nussbaum RL, et al: Physical fine mapping of the choroideremia locus using Xq21 deletions associated with complex syndromes. Genomics 4:41-46 (1989).
30. Crisponi L, Deiana M, Loi A, Chiappe F, Uda M, et al: The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ ptosis/epicanthus inversus syndrome. Nat Genet 27:159-166 (2001).
31. Cutler WB, Genovese-Stone E: Wellness in women after 40 years of age: the role of sex hormones and pheromones. Dis Mon 44:421-546 (1998).
32. De Baere E, Lemercier B, Christin-Maitre S, Durval D, Messiaen L, et al: FOXL2 mutation screening in a large panel of POF patients and XX males. J Med Genet 39:e43 (2002).
33. Di Cristofano A, Pesce B, Cordon-Cardo C, Pandolfi PP: Pten is essential for embryonic development and tumour suppression. Nat Genet 19:348-355 (1998).
34. Di Pasquale E, Beck-Peccoz P, Persani L: Hypergonadotropic ovarian failure associated with an inherited mutation of human bone morphogenetic protein-15 (BMP15) gene. Am J Hum Genet 75:106-111 (2004).
35. Di Pasquale E, Rossetti R, Marozzi A, Bodega B, Borgato S, et al: Identification of new variants of human BMP15 gene in a large cohort of women with premature ovarian failure. J Clin Endocrinol Metab 91:1976-1979 (2006).
36. Diaz FJ, Wigglesworth K, Eppig JJ: The preantral granulosa cell to cumulus cell transition in the mouse ovary: development of competence to undergo expansion. Dev Biol 299:91-104 (2006).
37. Diaz FJ, Wigglesworth K, Eppig JJ: Oocytes determine cumulus cell lineage in mouse ovarian follicles. J Cell Sci 120:1330-1340 (2007a).
38. Diaz FJ, Wigglesworth K, Eppig JJ: Oocytes are required for the preantral granulosa cell to cumulus cell transition in mice. Dev Biol 305:300-311 (2007b).
39. Dierich A, Ram Sairam M, Monaco L, Maria Fimia G, Gansmuller A, et al: Impairing follicle stimulating hormone (FSH) signaling in vivo: targeted disruption of the FSH receptor leads to aberrant gametogenesis and hormonal imbalance. Proc Natl Acad Sci USA 95:13612-13617 (1998).
40. Dixit H, Rao LK, Padmalatha V, Kanakavalli M, Deenadayal M, et al: Mutational screening of the coding region of growth differentiation factor 9 gene in Indian women with ovarian failure. Menopause 12:749-754 (2005).
41. Dixit H, Rao LK, Padmalatha VV, Kanakavalli M, Deenadayal M, et al: Missense mutations in the BMP15 gene are associated with ovarian failure. Hum Genet 119:408-415 (2006).
42. Doherty E, Pakarinen P, Tiitinen A, Kiilavuori A, Huhtaniemi I, et al: A novel mutation in the FSH receptor inhibiting signal transduction and causing primary ovarian failure. J Clin Endocrinol Metab 87:1151-1155 (2002).
43. Dong J, Albertini DF, Nishimori K, Kumar TR, Lu N, Matzuk MM: Growth differentiation factor-9 is required during early ovarian folliculogenesis. Nature 383:531-535 (1996).
44. Dube JL, Wang P, Elvin J, Lyons KM, Celeste AJ, Matsuk MM: The bone morphogenetic protein 15 gene is X-linked and expressed in oocytes. Mol Endocrinol 12:1809-1817 (1998).
45. Ebralidze A, Wang Y, Petkova V, Ebralidse K, Junghans RP: RNA leaching of transcription factors disrupts transcription in myotonic dystrophy. Science 303:383-387 (2004).
46. Elvin JA, Yan C, Wang P, Nishimori K, Matzuk MM: Molecular characterization of the follicle defects in the growth differentiation factor 9-deficient ovary. Mol Endocrinol 13:1018-1034 (1999).
47. Elvin JA, Yan C, Matzuk MM: Oocyte-expressed TGF-beta superfamily members in female fertility. Mol Cell Endocrinol 159:1-5 (2000).
48. Epifano O, Liang LF, Famiari M, Moos MC, Dean J: Coordinate expression of the three zona pellucida genes during mouse oogenesis. Development 121:1947-1956 (1995).
49. Eppig J: Mouse oocytes control metabolic co-operativity between oocytes and cumulus cells. Reprod Fertil Dev 17:1-2 (2005).
50. Falender AE, Shimada M, Lo YK, Richards JS: TAF4b, a TBP associated factor, is required for oocyte development and function. Dev Biol 288:405-419 (2005).
51. kip1 deficient mice. Cell 85:733-744 (1996).
52. Freiman RN, Albright SR, Zheng S, Sha WC, Hammer RE, Tjian R: Requirement of tissue-selective TBP-associated factor TAFII105 in ovarian development. Science 293:2084-2087 (2001).
53. Fu YH, Kuhl DP, Pizzuti A, Pieretti M, Sutcliffe JS, et al: Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell 67:1047-1058 (1991).
54. Fujiwara Y, Komiya T, Kawabata H, Sato M, Fujimoto H, et al: Isolation of a DEAD-family protein gene that encodes a murine homolog of Drosophila vasa and its specific expression in germ cell linage. Proc Natl Acad Sci USA 91:12258-12262 (1994).
55. Galloway SM, McNatty KP, Cambridge LM, Gaitinen MP, Juengel JL, et al: Mutations in an oocyte-derived growth factor gene (BMP15) cause increased ovulation rate and infertility in a dosage-sensitive manner. Nat Genet 25:279-283 (2000).
56. Gillio-Meina C, Hui YY, LaVoie HA: GATA-4 and GATA-6 transcription factors: expression, immunohistochemical localization, and possible function in the porcine ovary. Biol Reprod 68:412-422 (2003).
57. Gittens JE, Mhawi AA, Lidington D, Ouellette Y, Kidder GM: Functional analysis of gap junctions in ovarian granulose cells: distinct role for connexin43 in early stages of folliculogenesis. Am J Physiol Cell Physiol 284:C880-C887 (2003).
58. Gosden RG: Gonadal tissue cryopreservation and transplantation. Reprod Biomed Online 1:64-67 (2002).
59. Gosden RG: Prospects for oocyte banking and in vitro maturation. J Natl Cancer Inst Monogr 34:60-63 (2005).
60. Gosden RG, Faddy MJ: Biological bases of premature ovarian failure. Reprod Fertil Dev 10:73-78 (1998).
61. Goswami D, Conway GS: Premature ovarian failure. Hum Reprod Update 11:391-410 (2005).
62. Gromoll J, Simoni M, Nordhoff V, Behre HM, De Geyter C, Nieschlag E: Functional and clinical consequences of mutations in the FSH receptor. Mol Cell Endocrinol 125:177-182 (1996).
63. Hagerman PJ, Hagerman RJ: The fragile-X premutation: a maturing perspective. Am J Hum Genet 74:805-816 (2004).
64. Harris SE, Chand AL, Winship IM, Gersak K, Aittomäki K, Shelling AN: Identification of novel mutations in FOXL2 associated with premature ovarian failure. Mol Hum Reprod 8:729-733 (2002).
65. Heikinheimo M, Ermolaeva M, Bielinska M, Rahman NA, Narita N, et al: Expression and hormonal regulation of transcription factors GATA-4 and GATA-6 in the mouse ovary. Endocrinology 138:3505-3514 (1997).
66. Hundscheid RD, Sistermans EA, Thomas CM, Braat DD, Straatman H, et al: Imprinting effect in premature ovarian failure confined to paternally inherited fragile X premutations. Am J Hum Genet 66:413-418 (2000).
67. Huntriss J, Gosden R, Hinkins M, Oliver B, Miller D, et al: Isolation, characterization and expression of the human factor in the germline alpha (FIGLA) gene in ovarian follicles and oocytes. Mol Hum Reprod 8:1087-1095 (2002).
68. Huntriss J, Hinkins M, Picton HM: cDNA cloning and expression of the human NOBOX gene in oocytes and ovarian follicles. Mol Hum Reprod 12:283-289 (2006).
69. Jacobsen BK, Heuch I, Kvale G: Age at natural menopause and all-cause mortality: a 37-year follow-up of 19,731 Norwegian women. Am J Epidemiol 157:923-929 (2003).
70. Joshi S, Davies H, Sims LP, Levy SE, Dean J: Ovarian gene expression in the absence of FIGLA, an oocyte-specific transcription factor. BMC Dev Biol 13:67 (2007).
71. Kalantaridou SN, Naka KK, Bechlioulis A, Makrigiannakis A, Michalis L, Chrousos GP: Premature ovarian failure, endothelial dysfunction and estrogen-progestogen replacement. Trends Endocrinol Metab 17:101-109 (2006).
72. kip1 puzzle. Cell 128:241-244 (2007).
73. Katz D, Niederberger C, Slaughter GR, Cooney AJ: Characterization of germ cell-specific expression of the orphan nuclear receptor, germ cell nuclear factor. Endocrinology 138:4364-4372 (1997).
74. Kehler J, Tolkunova E, Koschorz B, Pesce M, Gentile L, et al: Oct4 is required for primordial germ cell survival. EMBO Rep 5:1078-1083 (2004).
75. Kerr CL, Hill CM, Blumenthal PD, Gearhart JD: Expression of pluripotent stem cell markers in the human fetal ovary. Hum Reprod 23:589-599 (2008).
76. Kidder GM, Mhawi AA: Gap junctions and ovarian folliculogenesis. Reproduction 123:613-620 (2002).
77. kip1. Cell 85:721-732 (1996).
78. Kovanci E, Rohozinski J, Simpson JL, Heard MJ, Bishop CE, Carson SA: Growth differentiating factor-9 mutations may be associated with premature ovarian failure. Fertil Steril 87:143-146 (2007a).
79. Kovanci E, Simpson JL, Amato P, Rohozinski J, Heard MJ, et al: Oocyte-specific G-protein-coupled receptor 3 (GPR3): no perturbations found in 82 women with premature ovarian failure (first report). Fertil Steril 90 (2007b).
80. Krauss CM, Turksoy RN, Atkins L, McLaughlin C, Brown LG, Page DC: Familial premature ovarian failure due to an interstitial deletion of the long arm of the X chromosome. N Engl J Med 317:125-131 (1987).
81. Kumar TR, Wang Y, Lu N, Matzuk MM: Follicle stimulating hormone is required for ovarian follicle maturation but not male fertility. Nat Genet 15:201-204 (1997).
82. Kurosaka S, Eckardt S, McLaughlin KJ: Pluripotent lineage definition in bovine embryos by Oct4 transcript localization. Biol Reprod 71:1578-1582 (2004).
83. Kwintkiewicz J, Cai Z, Stocco C: Follicle-stimulating hormone-induced activation of Gata4 contributes in the up-regulation of Cyp19 expression in rat granulosa cells. Mol Endocrinol 21:933-947 (2007).
84. Lachlan KL, Youings S, Costa T, Jacobs PA, Thomas NS: A clinical and molecular study of 26 females with Xp deletions with special emphasis on inherited deletions. Hum Genet 118:640-651 (2006).
85. Lacombe A, Lee H, Zahed L, Choucair M, Muller J, et al: Disruption of POF1B binding to nonmuscle actin filaments is associated with premature ovarian failure. Am J Hum Genet 79:113-119 (2006).
86. Laissue P, Christin-Maitre S, Touraine P, Kuttenn F, Ritvos O, et al: Mutations and sequence variants in GDF9 and BMP15 in patients with premature ovarian failure. Eur J Endocrinol 154:739-744 (2006).
87. Laitinen MP, Anttonen M, Ketola I, Wilson DB, Ritvos O, et al: Transcription factors GATA-4 and GATA-6 and a GATA family cofactor, FOG-2 , are expressed in human ovary and sex cord-derived ovarian tumors. J Clin Endocrinol Metab 85:3476-3483 (2000).
88. Laml T, Schulz-Lobmeyr I, Obruca A, Huber JC, Hartmann BW: Premature ovarian failure: etiology and prospects. Gynecol Endocrinol 14:292-302 (2000).
89. Lan ZJ, Gu P, Xu X, Cooney AJ: Expression of the orphan nuclear receptor, germ cell nuclear factor, in mouse gonads and preimplantation embryos. Biol Reprod 68:282-289 (2003a).
90. Lan ZJ, Gu P, Xu X, Jackson KJ, DeMayo FJ, et al: GCNF-dependent repression of BMP-15 and GDF-9 mediates gamete regulation of female fertility. EMBO J 22:4070-4081 (2003b).
91. Lan ZJ, Xu X, Cooney AJ: Differential oocyte-specific expression of Cre recombinase activity in GDF-9ICre, Zp3cre, and Msx2Cre transgenic mice. Biol Reprod 71:1469-1474 (2004).
92. Lasko PF, Ashburner M: The product of the Drosophila gene vasa is very similar to eukaryotic initiation factor-4A. Nature 335:611-617 (1988).
93. Lavoie HA, McCoy GL, Blake CA: Expression of the GATA-4 and GATA-6 transcription factors in the fetal rat gonad and in the ovary during postnatal development and pregnancy. Mol Cell Endocrinol 227:31-40 (2004).
94. Ledent C, Demeestere I, Blum D, Petermans J, Hämäläinen T, et al: Premature ovarian aging in mice deficient for Gpr3. Proc Natl Acad Sci USA 102:8922-8926 (2005).
95. Ledig S, Röpke A, Haeusler G, Hinney B, Wieacker P: BMP15 mutations in XX gonadal dysgenesis and premature ovarian failure. Am J Obstet Gynecol 198:84.e1-5 (2008).
96. Li S, Lu MM, Zhou D, Hammes SR, Morrisey EE: GLP-1: a novel zinc finger protein required in somatic cells of the gonad for germ cell development. Dev Biol 301:106-116 (2007).
97. Liang L, Soyal SM, Dean J: FIGalpha, a germ cell specific transcription factor involved in the coordinate expression of the zona pellucida genes. Development 124:4939-4947 (1997).
98. Liao WX, Moore RK, Otsuka F, Shimasaki S: Effect of intracellular interactions on the processing and secretion of bone morphogenetic protein-15 (BMP-15) and growth and differentiation factor-9. Implication of the aberrant ovarian phenotype of BMP-15 mutant sheep. J Biol Chem 278:3713-3719 (2003).
99. Liao WX, Moore RK, Shimasaki S: Functional and molecular characterization of naturally occurring mutations in the oocyte-secreted factors bone morphogenetic protein-15 and growth and differentiation factor-9. J Biol Chem 279:17391-17396 (2004).
100. Lin Y, Page DC: Dazl deficiency leads to embryonic arrest of germ cell development in XY C57BL/6 mice. Dev Biol 288:309-316 (2005).
101. Liu K, Rajareddy S, Liu L, Jagarlamudi K, Boman K, et al: Control of mammalian oocyte growth and early follicular development by the oocyte P13 kinase pathway: new roles for an old timer. Dev Biol 299:1-11 (2006).
102. Liu L, Rajareddy S, Reddy P, Du C, Jagarlamudi K, et al: Infertility caused by retardation of follicular development in mice with oocyte-specific expression of Foxo3a. Development 134:199-209 (2007).
103. Loffler KA, Zarkower D, Koopman P: Etiology of ovarian failure in blepharophimosis ptosis epicanthus inversus syndrome: FOXL2 is a conserved, early-acting gene in vertebrate ovarian development. Endocrinology 144:3237-3243 (2003).
104. Maraschio P, Tupler R, Barbierato L, Dainotti E, Larizza D, et al: An analysis of Xq deletions. Hum Genet 97:375-381 (1996).
105. Marozzi A, Manfredini E, Tibiletti MG, Furlan D, Villa N, et al: Molecular definition of Xq common-deleted region in patients affected by premature ovarian failure. Hum Genet 107:304-311 (2000).
106. Matzuk MM, Lamb DJ: Genetic dissection of mammalian fertility pathways. Nat Cell Biol 4 Suppl:s41-s49 (2002).
107. McCoard SA, Wise TH, Fahrenkrug SC, Ford JJ: Temporal and spatial localization patterns of Gata4 during porcine gonadogenesis. Biol Reprod 65:366-374 (2001).
108. McCoard SA, Wise TH, Ford JJ: Expression levels of Mullerian-inhibiting substance, GATA4 and 17alpha-hydroxylase/17,20-lyase cytochrome P450 during embryonic gonadal development in two diverse breeds of swine. J Endocrinol 175:365-374 (2002).
109. McGrath SA, Esquela AF, Lee SJ: Oocyte-specific expression of growth/differentiation factor-9. Mol Endocrinol 9:131-136 (1995).
110. McNatty KP, Smith P, Moore LG, Reader K, Lun S, et al: Oocyte-expressed genes affecting ovulation rate. Mol Cell Endocrinol 234:57-66 (2005).
111. McNeilly JR, Saunders PT, Taggart M, Cranfield M, Cooke HJ, McNeilly AS: Loss of oocytes in Dazl knockout mice results in maintained ovarian steroidogenic function but altered gonadotropin secretion in adult animals. Endocrinology 141:4284-4294 (2000).
112. Meduri G, Touraine P, Beau I, Lahuna O, Desroches A, et al: Delayed puberty and primary amenorrhea associated with a novel mutation of the human follicle-stimulating hormone receptor: clinical, histological, and molecular studies. J Clin Endocrinol Metab 88:3491-3498 (2003).
113. Mehlmann LM: Oocyte-specific expression of Gpr3 is required for the maintenance of meiotic arrest in mouse oocytes. Dev Biol 288:397-404 (2005a).
114. Mehlmann LM: Stops and starts in mammalian oocytes: recent advances in understanding the regulation of meiotic arrest and oocyte maturation. Reproduction 130:791-799 (2005b).
115. Mehlmann LM, Saeki Y, Tanaka S, Brennan TJ, Evsikov AV, et al: The Gs-linked receptor GPR3 maintains meiotic arrest in mammalian oocytes. Science 306:1947-1950 (2004).
116. Moore RK, Shimasaki S: Molecular biology and physiological role of the oocyte factor, BMP-15. Mol Cell Endocrinol 234:67-73 (2005).
117. Moore RK, Erickson GF, Shimasaki S: Are BMP-15 and GDF-9 primary determinants of ovulation quota in mammals? Trends Endocrinol Metab 15:356-361 (2004).
118. Murray A: Premature ovarian failure and the FMR1 gene. Semin Reprod Med 18:59-66 (2000).
119. Murray A, Ennis S, MacSwiney F, Webb J, Morton NE: Reproductive and menstrual history of females with fragile X expansions. Eur J Hum Genet 8:247-252 (2000).
120. kip1 display increased body size, multiple organ hyperplasia rentinal dysplasia, and pituitary tumors. Cell 85:707-720 (1996).
121. Oberle I, Rousseau F, Heitz D, Kretz C, Devys D, et al: Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome. Science 252:1097-1102 (1991).
122. Ogata T, Matsuo N: Turner syndrome and female sex chromosome aberrations: deduction of the principal factors involved in the development of clinical features. Hum Genet 95:607-629 (1995).
123. Ogata T, Muroya K, Matsuo N, Shinohara O, Yorifuji T, et al: Turner syndrome and Xp deletions: clinical and molecular studies in 47 patients. J Clin Endocrinol Metab 86:5498-5508 (2001).
124. Ongeri EM, Verderame MF, Hammond JM: The TATA binding protein associated factor 4b (TAF4b) mediates FSH stimulation of the IGFBP-3 promoter in cultured porcine ovarian granulosa cells. Mol Cell Endocrinol 278:29-35 (2007).
125. Otsuka F, Yao Z, Lee T, Yamamoto S, Erickson GF, Shimasaki S: Bone morphogenetic protein-15. Identification of target cells and biological functions. J Biol Chem 275:39523-39528 (2000).
126. Otsuka F, Yamamoto S, Erickson GF, Shimasaki S: Bone morphogenetic protein-15 inhibits follicle-stimulating hormone (FSH) action by suppressing FSH receptor expression. J Biol Chem 276:11387-11392 (2001).
127. Ottolenghi C, Omari S, Garcia-Ortiz JE, Uda M, Crisponi L, et al: Foxl2 is required for commitment to ovary differentiation. Hum Mol Genet 14:2053-2062 (2005).
128. Ottolenghi C, Pelosi E, Tran J, Colombino M, Douglass E, et al: Loss of Wnt4 and Foxl2 leads to female-to-male sex reversal extending to germ cells. Hum Mol Genet 16:2795-2804 (2007).
129. Pal L, Santoro N: Premature ovarian failure (POF): discordance between somatic and reproductive aging. Ageing Res Rev 1:413-423 (2002).
130. Pangas SA, Rajkovic A: Transcriptional regulation of early oogenesis: in search of masters. Hum Reprod Update 12:65-76 (2006).
131. Pangas SA, Choi Y, Ballow DJ, Zhao Y, Westphal H, et al: Oogenesis requires germ cell-specific transcriptional regulators Sohlh1 and Lhx8. Proc Natl Acad Sci USA 103:8090-8095 (2006).
132. Pennetier S, Uzbekova S, Perreau C, Papillier P, Mermillod P, Dalbiès-Tran R: Spatio-temporal expression of the germ cell marker genes MATER, ZAR1, GDF9, BMP15, and VASA in adult bovine tissues, oocytes, and preimplantation embryos. Biol Reprod 71:1359-1366 (2004).
133. Perez GI, Jurisicova A, Wise L, Lipina T, Kanisek M, et al: Absence of the proapoptotic Bax protein extends fertility and alleviates age-related health complications in female mice. Proc Natl Acad Sci USA 104:5229-5234 (2007).
134. Pesce M, Schöler HR: Oct-4: control of totipotency and germline determination. Mol Reprod Dev 55:452-457 (2000).
135. Pesce M, Gross MK, Schöler HR: In line with our ancestors: Oct-4 and the mammalian germ. Bioessays 20:722-732 (1998).
136. Podsypanina K, Ellenson LH, Nemes A, Gu J, Tamura M, et al: Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. Proc Natl Acad Sci USA 96:1563-1568 (1999).
137. Qin Y, Choi Y, Zhao H, Simpson JL, Chen ZJ, Rajkovic A: NOBOX homeobox mutation causes premature ovarian failure. Am J Hum Genet 81:576-581 (2007).
138. Qin Y, Zhao H, Kovanci E, Simpson JL, Chen ZJ, Rajkovic A: Analysis of LHX8 mutation in premature ovarian failure. Fertil Steril 89:1012-1014 (2008).
139. Rajareddy S, Reddy P, Du C, Liu L, Jagarlamudi K, et al: p27 kip1 (cyclin-dependent kinase inhibitor 1B) controls ovarian development by suppressing follicle endowment and activation and promoting follicle atresia in mice. Mol Endocrinol 21:2189-2202 (2007).
140. Rajkovic A, Pangas SA, Ballow D, Suzumori N, Matzuk MM: NOBOX deficiency disrupts early folliculogenesis and oocyte-specific gene expression. Science 305:1157-1159 (2004).
141. Reddy P, Shen L, Ren C, Boman K, Lundin E, et al: Activation of Akt (PKB) and suppression of FKHRL1 in mouse and rat oocytes by stem cell factor during follicular activation and development. Dev Biol 281:160-170 (2005).
142. Reddy P, Liu L, Adhikari D, Jagarlamudi K, Rajareddy S, et al: Oocyte-specific deletion of Pten causes premature activation of the primordial follicle pool. Science 319:611-613 (2008).
143. Rizzolio F, Bione S, Sala C, Goegan M, Gentile M, et al: Chromosomal rearrangements in Xq and premature ovarian failure: mapping of 25 new cases and review of the literature. Hum Reprod 21:1477-1483 (2006).
144. Rizzolio F, Bione S, Villa A, Berti E, Cassetti A, et al: Spatial and temporal expression of POF1B , a gene expressed in epithelia. Gene Expr Patterns 7:529-534 (2007).
145. Rosetti F, Rizzolio F, Pramparo T, Sala C, Bione S, et al: A susceptibility gene for premature ovarian failure (POF) maps to proximal Xq28. Eur J Hum Genet 12:829-834 (2004).
146. Ruggiu M, Speed R, Taggart M, McKay SJ, Kilanowski F, et al: The mouse Dazla gene encodes a cytoplasmic protein essential for gametogenesis. Nature 389:73-77 (1997).
147. Schmidt D, Ovitt CE, Anlag K, Fehsenfeld S, Gredsted L, et al: The murine winged-helix transcription factor Foxl2 is required for granulosa cell differentiation and ovary maintenance. Development 131:933-942 (2004).
148. Schwartz C, Fitch N, Phelan MC, Richer CL, Stevenson R: Two sisters with a distal deletion at the Xq26/Xq27 interface: DNA studies indicate that the gene locus for factor IX is present. Hum Genet 76:54-57 (1987).
149. Seligman J, Page DC: The Dazh gene is expressed in male and female embryonic gonads before germ cell sex differentiation. Biochem Biophys Res Commun 245:878-882 (1998).
150. Senöz S, Direm B, Gülekli B, Gökmen O: Estrogen deprivation, rather than age, is responsible for the poor lipid profile and carbohydrate metabolism in women. Maturitas 25:107-114 (1996).
151. Silverman E, Eimerl S, Orly J: CCAAT enhancer-binding protein beta and GATA-4 binding regions within the promoter of the steroidogenic acute regulatory protein (StAR) gene are required for transcription in rat ovarian cells. J Biol Chem 274:17987-17996 (1999).
152. Silverman E, Yivgi-Ohana N, Sher N, Bell M, Eimerl S, Orly J: Transcriptional activation of the steroidogenic acute regulatory protein (StAR) gene: GATA-4 and CCAAT/enhancer-binding protein beta confer synergistic responsiveness in hormone-treated rat granulosa and HEK293 cell models. Mol Cell Endocrinol 252:92-101 (2006).
153. Simon AM, Goodenough DA, Li E, Paul DL: Female infertility in mice lacking connexin 37. Nature 385:525-529 (1997).
154. Simpson JL, Rajkovic A: Ovarian differentiation and gonadal failure. Semin Med Genet 89:186-200 (1999).
155. Smith P, O WS, Corrigan KA, Smith T, Lundy T, et al: Ovarian morphology and endocrine characteristics of female sheep fetuses that are heterozygous or homozygous for the inverdale prolificacy gene (fecX1). Biol Reprod 57:1183-1192 (1997).
156. Snieder H, MacGregor AJ, Spector TD: Genes control the cessation of a woman's reproductive life: a twin study of hysterectomy and age at menopause. J Clin Endocrinol Metab 83:1875-1880 (1998).
157. Song JL, Wessel GM: How to make an egg: transcriptional regulation in oocytes. Differentiation 73:1-17 (2005).
158. Soyal SM, Amleh A, Dean J: FIGalpha, a germ cell-specific transcription factor required for ovarian follicle formation. Development 127:4645-4654 (2000).
159. Speroff L, Fritz MA (eds): Amenorrhea, in Clinical Gynecologic Endocrinology and Infertility, 7th ed., pp 401-464 (Lippincott Williams and Wilkins, Philadelphia 2005).
160. Stambolic V, Suzuki A, de la Pompa JL, Brothers GM, Mirtsos C, et al: Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95:29-39 (1998).
161. Stoop H, Honecker F, Cools M, de Krijger R, Bokemeyer C, Looijenga LH: Differentiation and development of human female germ cells during prenatal gonadogenesis: an immunohistochemical study. Hum Reprod 20:1466-1476 (2005).
162. Sullivan AK, Marcus M, Epstein MP, Allen EG, Anido AE, et al: Association of FMR1 repeat size with ovarian dysfunction. Hum Reprod 20:402-412 (2005).
163. Sundblad V, Chiauzzi VA, Escobar ME, Dain L, Charreau EH: Screening of FSH receptor gene in Argentine women with premature ovarian failure (POF). Mol Cell Endocrinol 222:53-59 (2004).
164. Suzuki A, de la Pompa JL, Stambolic V, Elia AJ, Sasaki T, et al: High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice. Curr Biol 8:1169-1178 (1998).
165. Suzumori N, Yan C, Matzuk MM, Rajkovic A: Nobox is a homeobox-encoding gene preferentially expressed in primordial and growing oocytes. Mech Dev 111:137-141 (2002).
166. Suzumori N, Pangas SA, Rajkovic A: Candidate genes for premature ovarian failure. Curr Med Chem 14:353-357 (2007).
167. Takakura K, Takebayashi K, Wang H, Kimura F, Kasahara K, Noda Y: Follicle-stimulating hormone receptor gene mutations are rare in Japanese women with premature ovarian failure and polycystic ovary syndrome. Fertil Steril 75:207-209 (2001).
168. Tanaka SS, Toyooka Y, Akasu R, Katoh-Fukui Y, Nakahara Y, et al: The mouse homolog of Drosophila Vasa is required for the development of male germ cells. Genes Dev 14:841-853 (2000).
169. Thomas FH, Ethier JF, Shimasaki S, Vanderhyden BC: Follicle-stimulating hormone regulates oocyte growth by modulation of expression of oocyte and granulosa cell factors. Endocrinology 146:941-949 (2005).
170. Toniolo D, Rizzolio F: X chromosome and ovarian failure. Semin Reprod Med 25:264-271 (2007).
171. Touraine P, Beau I, Gougeon A, Meduri G, Desroches A, et al: New natural inactivating mutations of the follicle-stimulating hormone receptor: correlations between receptor function and phenotype. Mol Endocrinol 13:1844-1854 (1999).
172. Tremblay JJ, Viger RS: GATA factors differentially activate multiple gonadal promoters through conserved GATA regulatory elements. Endocrinology 142:977-986 (2001).
173. Trunca C, Therman E, Rosenwaks Z: The phenotypic effects of small, distal Xq deletions. Hum Genet 68:87-89 (1984).
174. Tung JY, Rosen MP, Nelson LM, Turek PJ, Witte JS, et al: Variants in Deleted in Azoospermia-Like (DAZL) are correlated with reproductive parameters in men and women. Hum Genet 118:730-740 (2006).
175. Uda M, Ottolenghi C, Crisponi L, Garcia JE, Deiana M, et al: Foxl2 disruption causes mouse ovarian failure by pervasive blockage of follicle development. Hum Mol Genet 13:1171-1181 (2004).
176. Udar N, Yellore V, Chalukya M, Yelchits S, Silva-Garcia R, et al: Comparative analysis of the FOXL2 gene and characterization of mutations in BPES patients. Hum Mutat 22:222-228 (2003).
177. Uygur D, Sengul O, Bayar D, Erdinc S, Batioglu S, Mollamahmutoglu L: Bone loss in young women with premature ovarian failure. Arch Gynecol Obstet 273:17-19 (2005).
178. Uzielli ML, Guarducci S, Lapi E, Cecconi A, Ricci U, et al: Premature ovarian failure (POF) and fragile X premutation females: from POF to fragile X carrier identification, from fragile X carrier diagnosis to POF association data. Am J Med Genet 84:300-303 (1999).
179. van Asselt KM, Kok HS, Pearson PL, Dubas JS, Peeters PH, et al: Heritability of menopausal age in mothers and daughters. Fertil Steril 82:1348-1351 (2004).
180. van der Schouw YT, van der Graaf Y, Steyerberg EW, Eijkemans JC, Banga JD: Age at menopause as a risk factor for cardiovascular mortality. Lancet 347:714-718 (1996).
181. Vaskivuo TE, Anttonen M, Herva R, Billig H, Dorland M, et al: Survival of human ovarian follicles from fetal to adult life: apoptosis, apoptosis-related proteins, and transcription factor GATA-4. J Clin Endocrinol Metab 86:3421-3429 (2001).
182. Vaskivuo TE, Aittomäki K, Anttonen M, Ruokonen A, Herva R, et al: Effects of follicle-stimulating hormone (FSH) and human chorionic gonadotropin in individuals with an inactivating mutation of the FSH receptor. Fertil Steril 78:108-113 (2002).
183. Vegetti W, Grazia Tibiletti M, Testa G, de Lauretis Y, Alagna F, et al: Inheritance in idiopathic premature ovarian failure: analysis of 71 cases. Hum Reprod 13:1796-1800 (1998).
184. Verkerk AJ, Pieretti M, Sutcliffe JS, Fu YH, Kuhl DP, et al: Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 65:905-914 (1991).
185. Vinci G, Christin-Maitre S, Pasquier M, Bouchard P, Fellous M, Veitia RA: FOXO3a variants in patients with premature ovarian failure. Clin Endocrinol (Oxf) 68:491-497 (2008).
186. Voronina E, Lovasco LA, Gyuris A, Baumgartner RA, Parlow AF, Freiman RN: Ovarian granulosa cell survival and proliferation requires the gonad-selective TFIID subunit TAF4b. Dev Biol 303:715-726 (2007).
187. Wang D, Kobayashi T, Zhou L, Nagahama Y: Molecular cloning and gene expression of Foxl2 in the Nile tilapia, Oreochromis niloticus. Biochem Biophys Res Commun 320:83-89 (2004).
188. Woad KJ, Watkins WJ, Prendergast D, Shelling AN: The genetic basis of premature ovarian failure. Aust N Z J Obstet Gynaecol 46:242-244 (2006).
189. Wu Y, Lu Y, Hu Y, Li R: Cyclic AMP-dependent modification of gonad-selective TAF(II)105 in a human ovarian granulosa cell line. J Cell Biochem 96:751-759 (2005).
190. Yan C, Wang P, DeMayo J, DeMayo FJ, Elvin JA, et al: Synergistic roles of bone morphogenetic protein 15 and growth differentiation factor 9 in ovarian function. Mol Endocrinol 15:854-866 (2001).
191. Zerbetto I, Gromoll J, Luisi S, Reis FM, Nieschlag E, et al: Follicle-stimulating hormone receptor and DAZL gene polymorphisms do not affect the age of menopause. Fertil Steril [Epub ahead of print] (2008).
192. Zhang P, Kerkela E, Skottman H, Levkov L, Kivinen K, et al: Distinct sets of developmentally regulated genes that are expressed by human oocytes and human embryonic stem cells. Fertil Steril 87:677-690 (2007).
193. Zhang YL, Akmal KM, Tsuruta JK, Shang Q, Hirose T, et al: Expression of germ cell nuclear factor (GCNF/RTR) during spermatogenesis. Mol Reprod Dev 50:93-102 (1998).
194. Zhao H, Qin Y, Kovanci E, Simpson JL, Chen ZJ, Rajkovic A: Analyses of GDF9 mutation in 100 Chinese women with premature ovarian failure. Fertil Steril 88:1474-1476 (2007).
195. Zhao H, Chen Z, Qin Y, Shi Y, Wang S, et al: Transcription factor FIGLA is mutated in patients with premature ovarian failure. Am J Hum Genet 82:1342-1348 (2008).
196. Zhao XX, Suzumori N, Yamaguchi M, Suzumori K: Mutational analysis of the homeobox region of the human NOBOX gene in Japanese women who exhibit premature ovarian failure. Fertil Steril 83:1843-1844 (2005).
197. Zheng P, Dean J: Oocyte-specific genes affect folliculogenesis, fertilization, and early development. Semin Reprod Med 25:243-251 (2007).
198. Zinn AR, Ross JL: Turner syndrome and haploinsufficiency. Curr Opin Genet Dev 8:322-327 (1998).
199. Zinn AR, Tonk VS, Chen Z, Flejter WL, Gardner HA, et al: Evidence for a Turner syndrome locus or loci at Xp11.2-p22.1. Am J Hum Genet 63:1757-1766 (1998).
200. Zwaka TP, Thomson JA: A germ cell origin of embryonic stem cells? Development 132:227-233 (2005).